Schedule 13G ownership disclosure
NOVELION THERAPEUTICS, INC.
Security class unavailable · CUSIP: 67001K202
Event date: 2019-05-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,144,554
- Percent of class
- 6.0100%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001687888-19-000004
- Form type
- SC 13G
- Filer
- JFL Capital Management, LLC
- CIK
- CIK 1687888
- Filed
- May 31, 2019
- Reporting period
- May 24, 2019
- Description
- Schedule 13G beneficial ownership